11-Aug-2025
Download PDF
Pfizer
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we hereby inform that Company has announced the launch of its next generation 20-valent Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) I.P. 20 - valent (PCV20) for adults in India on August 11 2025.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
Widely read:
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
